Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | metallo-peptidase, Clan MG, Family M24 | 0.1273 | 1 | 1 |
Loa Loa (eye worm) | protein-tyrosine phosphatase | 0.0247 | 0.0799 | 0.0799 |
Loa Loa (eye worm) | initiation factor 2-associated protein | 0.1273 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytoplasmic peptidase PepQ | 0.0158 | 0 | 0.5 |
Mycobacterium tuberculosis | Dipeptidase PepE | 0.0158 | 0 | 0.5 |
Schistosoma mansoni | protein tyrosine phosphatase n11 (shp2) | 0.0247 | 0.0799 | 0.0799 |
Plasmodium falciparum | methionine aminopeptidase 2 | 0.1273 | 1 | 1 |
Trypanosoma brucei | metallo-peptidase, Clan MG, Family M24 | 0.1273 | 1 | 1 |
Trypanosoma cruzi | metallo-peptidase, Clan MG, Family M24 | 0.1273 | 1 | 1 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.1273 | 1 | 1 |
Mycobacterium ulcerans | methionine aminopeptidase | 0.0158 | 0 | 0.5 |
Mycobacterium leprae | Probable cytoplasmic peptidase PepQ | 0.0158 | 0 | 0.5 |
Mycobacterium ulcerans | dipeptidase PepE | 0.0158 | 0 | 0.5 |
Treponema pallidum | methionine aminopeptidase (map) | 0.0158 | 0 | 0.5 |
Mycobacterium ulcerans | dipeptidase | 0.0158 | 0 | 0.5 |
Treponema pallidum | aminopeptidase P | 0.0158 | 0 | 0.5 |
Echinococcus granulosus | tyrosine protein phosphatase non receptor type | 0.0247 | 0.0799 | 0.0799 |
Wolbachia endosymbiont of Brugia malayi | Xaa-Pro aminopeptidase | 0.0158 | 0 | 0.5 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.1273 | 1 | 1 |
Chlamydia trachomatis | methionine aminopeptidase | 0.0158 | 0 | 0.5 |
Entamoeba histolytica | methionine aminopeptidase, putative | 0.1273 | 1 | 1 |
Leishmania major | methionine aminopeptidase 2, putative | 0.1273 | 1 | 1 |
Echinococcus granulosus | methionyl aminopeptidase 2 | 0.1273 | 1 | 1 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPA (MAP) (PEPTIDASE M) (MetAP) | 0.0158 | 0 | 0.5 |
Echinococcus multilocularis | tyrosine protein phosphatase non receptor type | 0.0247 | 0.0799 | 0.0799 |
Schistosoma mansoni | methionyl aminopeptidase 2 (M24 family) | 0.1273 | 1 | 1 |
Giardia lamblia | Methionine aminopeptidase | 0.1273 | 1 | 1 |
Trypanosoma brucei | methionine aminopeptidase 2, putative | 0.1273 | 1 | 1 |
Mycobacterium ulcerans | aminopeptidase | 0.0158 | 0 | 0.5 |
Onchocerca volvulus | Methionine aminopeptidase 2 homolog | 0.1273 | 1 | 1 |
Echinococcus multilocularis | methionyl aminopeptidase 2 | 0.1273 | 1 | 1 |
Mycobacterium ulcerans | methionine aminopeptidase MapB | 0.0158 | 0 | 0.5 |
Echinococcus granulosus | tyrosine protein phosphatase non receptor type | 0.0247 | 0.0799 | 0.0799 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.1273 | 1 | 1 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapA (map) (peptidase M) (MetAP) | 0.0158 | 0 | 0.5 |
Plasmodium vivax | methionine aminopeptidase 2, putative | 0.1273 | 1 | 1 |
Toxoplasma gondii | methionine aminopeptidase 2, putative | 0.1273 | 1 | 1 |
Brugia malayi | Protein-tyrosine phosphatase containing protein | 0.0247 | 0.0799 | 0.0799 |
Chlamydia trachomatis | aminopeptidase P | 0.0158 | 0 | 0.5 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.1273 | 1 | 1 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPB (MAP) (PEPTIDASE M) | 0.0158 | 0 | 0.5 |
Echinococcus multilocularis | tyrosine protein phosphatase non receptor type | 0.0247 | 0.0799 | 0.0799 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapB (map) (peptidase M) | 0.0158 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | methionine aminopeptidase | 0.0158 | 0 | 0.5 |
Mycobacterium ulcerans | cytoplasmic peptidase PepQ | 0.0158 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.